Boston Partners Astrazeneca PLC Transaction History
Boston Partners
- $77.6 Billion
- Q4 2024
A detailed history of Boston Partners transactions in Astrazeneca PLC stock. As of the latest transaction made, Boston Partners holds 3,707,479 shares of AZN stock, worth $270 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
3,707,479
Previous 36,760
9985.63%
Holding current value
$270 Million
Previous $2.86 Million
8381.63%
% of portfolio
0.31%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,344Shares Held
478MCall Options Held
5.39MPut Options Held
3.79M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.57 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.98 Billion2.12% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.69 Billion0.46% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.68 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.42 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $225B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...